FDA Inspection 624796 — Jubilant Cadista Pharmaceuticals

Jubilant Cadista Pharmaceuticals — FEI 3017221809

The FDA completed an inspection of Jubilant Cadista Pharmaceuticals on Oct 29, 2009 in Yardley, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 29, 2009
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Yardley, PA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.